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Objective. To review recent data on the aetiology of cleft lip and palate.
Data sources. MEDLINE literature search (1986-2003).
Study selection. Literature and data on aetiology of cleft lip and palate using the
following key words: ‘cleft lip’, ‘cleft palate’, ‘aetiology’, and ‘genetics’.
Data extraction. Relevant information and data were reviewed by the authors.
Data synthesis. Cleft lip and palate is one of the most common types of
congenital malformation. The aetiology seems complex, but genetics plays
a major role. Recently several genes causing syndromic cleft lip and palate
have been discovered. Three of them—namely T-box transcription factor-22
(TBX22), poliovirus receptor like-1 (PVRL1), and interferon regulatory factor-6
(IRF6)—are responsible for causing X-linked cleft palate, cleft lip/palate-
ectodermal dysplasia syndrome, and Van der Woude’s and popliteal pterygium
syndromes, respectively; they are also implied in non-syndromic cleft lip
and palate. The nature and function of these genes vary widely, illustrating high
vulnerability within the craniofacial developmental pathways. The aetiological
complexity of non-syndromic cleft lip and palate is also exemplified by the large
number of candidate genes and loci.
Conclusions. The aetiology of non-syndromic cleft lip and palate is still largely
unknown, but mutations in candidate genes have already been identified in
a small proportion of cases of non-syndromic cleft lip and palate. Determining
the relative risk of cleft lip and palate, on the basis of genetic background
and environmental influence, including smoking, alcohol use, and dietary
factors, will aid in genetic counselling and the development of future preventive
measures.
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Introduction
Cleft lip and palate (CLP) comprises a group of the most common congenital
malformations. Immediately after birth, individuals with CLP have facial
deformation, feeding problems, and frequent middle ear infection, the treatments
of which require interventions from multiple disciplines. At the age of speech
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acquisition, speech therapy is often needed to correct
problems resulting from muscular defects of the cleft. As
the individual continues to grow, defects in tooth develop-
ment and malocclusion require dental and sometimes
surgical treatment. The lengthy series of treatment from
birth to adulthood is a heavy burden for the patient, family,
and society. Various efforts have been made to understand
the aetiology of CLP so as to predict its occurrence and
to prevent it from occurring in the future. In recent years,
advances in genetics and molecular biology have begun to
reveal the basis of craniofacial development, and a number
of genes associated with CLP have been identified. Studies
of the combined genetic and environmental cause of CLP
are also growing. This article reviews the recently
discovered genes involved in CLP, and provides an up-
date on the aetiological factors underlying this common
malformation.
Embryology
The lip and palatal regions are developed from the
embryonic primary and secondary palates. The primary
palate contributes to the lip, anterior tooth-bearing
alveolus, and the anterior palate up to the incisal
foramen. The secondary palate contributes to the re-
maining hard and soft palates. During the fourth week
of gestation, neural crest cells from the anterior neural
tube migrate to form the facial primordia, from which the
nasal and the lateral maxillary processes fuse to form the
primary palate. The secondary palate begins to form in
the sixth week of gestation. Palatal shelves initially
appear as two downward extensions from the inner side
of the left and right maxilla along the lateral surface of
the tongue. In the ninth week, the two palatal shelves
undergo a rapid horizontal transformation, by moving over
the tongue and fusing with each other and with the nasal
septum. Failure in the fusion of primary or secondary
palates leads to clefts of the respective areas. Thus, CLP
appears commonly as cleft lip with or without cleft palate
or isolated cleft palate.
Clinically, when CLP appears with other (usually two
or more) malformations in recognisable patterns, it is
classified as syndromic CLP (SCLP). If it appears as an
isolated defect or if syndromes cannot be identified, the
term non-syndromic CLP (NSCLP) is used. The number of
CLP syndromes is large and still growing. A search of the
Online Mendelian Inheritance in Man database using
the term ‘cleft lip’ yielded more than 200 entries and a
search using ‘cleft palate’ yielded close to 400.1 The
distinction between NSCLP and SCLP, however, is some-
times not clear-cut. In families with SCLP, some affected
members may present with only CLP, because of variable
expression of the syndrome. On the other hand, more
than 20% of patients with NSCLP were found to have
associated congenital malformations in one study.2 Thus,
some cases of SCLP and NSCLP might share a common
aetiology.
Recently discovered genes causing orofacial cleft
syndromes
T-box transcription factor-22
X-linked cleft palate (CPX) is characterised by isolated
cleft palate and ankyloglossia (tongue-tie); clinical
expression of CPX is highly variable. High-arched palate,
bifid uvula, or ankyloglossia could be the only presenting
sign in affected males. Female carriers could be asymptom-
atic or they could express full features of CPX. The
syndrome has been found in a number of large families
who show inheritance in a Mendelian X-linked semi-
dominant pattern. By using genetic linkage analysis, Stanier
et al3 located the disease gene locus to chromosome Xq21.
Braybrook et al4 performed extensive mutation analysis
of candidate genes in the region and found mutations of the
T-box transcription factor-22 gene (TBX22) in a large
Icelandic family with CPX and in several smaller families
from other countries. Animal experiments showed that
expression of TBX22 was highly restricted to the palatal
shelves just before their elevation to adopt a horizontal
position, and at the base of the tongue corresponding to
the frenulum, both of these expression patterns closely
matched the clinical presentation of CPX. Involvement of
TBX22 in NSCLP has recently been indicated from a
genome-wide sibling-pair analyses in which the chromo-
some Xcen-q region, where TBX22 is located, showed
promising multipoint logarithm of odds (LOD) scores.5
Mutation analysis of TBX22 in these patients could reveal
whether the gene is involved in NSCLP as well.
Poliovirus receptor like-1
Cleft lip/palate ectodermal dysplasia syndrome (CLPED)
is characterised by cleft lip with or without cleft palate,
hidrotic ectodermal dysplasia, syndactyly, and occasionally
mental retardation. Two other syndromes—the Zlotogora-
Ogur syndrome and Margarita Island ectodermal
dysplasia—are also classified as CLPED. The inheritance
of CLPED appears to be autosomal recessive. Using
positional cloning, Suzuki et al6 identified mutations of
the poliovirus receptor like-1 gene (PVRL1) in CLPED
families from Margarita Island, Israel, and Brazil.
The protein product of PVRL1 was initially identified
as poliovirus receptor-related protein (PRR). Takahashi
et al7 confirmed the function of PRR as a cell adhesion
molecule, and they renamed it nectin-1. All three PVRL1
mutations found in families with CLPED resulted in
truncatations in nectin-1, thereby destroying the
nectin-afadin-ponsin (NAP)–dependent cell-adhesion
system. In animal experiments, PVRL1 was expressed
at the medial edge epithelium of the palatal shelves and
the skin surface epithelium—locations that corresponded
to the clinical phenotypes of CLPED.6 Interestingly,
heterozygous mutation of PVRL1 (W185X) was associated
with NSCLP in northern Venezuela.8 Thus, a certain
proportion of NSCLP cases can be explained by PVRL1
mutations.
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Interferon regulatory factor-6
Van der Woude’s syndrome (VDWS) is the most common
form of SCLP and accounts for 2% of all CLP cases.9
This syndrome is characterised by cleft lip with or without
cleft palate, isolated cleft palate, pits or mucous cysts
on the lower lip, and hypodontia. Popliteal pterygium
syndrome (PPS) includes all the features of VDWS plus
popliteal pterygium, syngnathia, distinct toe/nail abnor-
mality, syndactyly, and genito-urinary malformations.
Owing to their clinical similarities, VDWS and PPS were
thought to be allelic—that is, caused by different mutations
of the same gene.10 Clinical expressions of VDWS and PPS
are also highly variable—for example, some family
members with VDWS present only with hypodontia, and in
PPS, popliteal pterygium is not always present.
The genetic locus for VDWS was localised to chromo-
some 1 back in 1990.11 Through linkage and chromosomal
analysis, the critical area for VDWS was gradually narrowed
to 1q32-q41. In 1999, PPS was also linked to the same
region.12 In 2002, Kondo et al13 described a pair of mono-
zygotic twins discordant for VDWS whose parents did not
have the disorder. The VDWS in the affected twin was
thought to arise from somatic mutation. Sequence analysis
revealed a point mutation in the interferon regulatory
factor-6 gene (IRF6), which is located within the VDWS
critical region. Additional mutations of IRF6 were found in
45 unrelated families with VDWS, as well as in 13 families
with PPS, thereby confirming a common genetic aetiology
in both syndromes.
In animal experiments, IRF6 was expressed in tissues
affected by both VDWS and PPS.13 The phenotypic
heterogeneity of VDWS and PPS was shown to be due to
different types of IRF6 mutation. In most cases of VDWS,
IRF6 mutations produced a non-functional protein and
haplo-insufficiency. The IRF6 mutations, however, were
missense mutations that affected the DNA binding domain
and caused a dominant-negative effect, which resulted in
severe phenotypes. A partial or modifying role of IRF6 in
NSCLP has been demonstrated in a study applying the
transmission disequilibrium test, in which specific parental
alleles at the VDWS locus were preferentially transmitted
to the individuals with NSCLP.14
Candidate genes or loci for non-syndromic cleft
lip and palate
Transforming growth factor-alpha
In 1989, Ardinger et al15 showed in a case-control study
that transforming growth factor-alpha (TGFA) was
associated with NSCLP. A number of follow-up studies
in different populations provided mixed results. Machida
et al16 sequenced the TGFA gene in a group of NSCLP
patients and found five mutations that could be aetiological
to orofacial clefts. The combined effect of TGFA mutation
and environmental influence in NSCLP has been analysed
by several groups of researchers. The rare TGFA variant
(TaqI C2 allele) and maternal smoking could increase the
risk of cleft palate by 6 to 8 times17 and of cleft lip with or
without cleft palate by 2 times.18 If multivitamins were not
consumed during the first trimester of pregnancy and the
baby is carrying the TGFA TaqI C2 allele, the relative risk
for cleft lip with or without cleft palate increased by 3 to 8
times.19
Drosophila msh homeo box homolog-1
Mice lacking functional Drosophila msh homeo box
homolog-1 (MSX1) develop a cleft of the secondary
palate and tooth agenesis.20 In humans, MSX1 mutation
was first shown to cause an autosomal dominant form
of tooth agenesis.21 Subsequently, van den Boogaard et al22
described a family with a common pattern of tooth
agenesis plus a mixture of cleft lip with or without
cleft palate and cleft palate. Direct sequencing of MSX1
revealed a disease-causing mutation. Recently, a large-
scale sequence analysis of MSX1 performed on 917
CLP patients identified mutations in 16 patients with
cleft lip with or without cleft palate, or cleft palate alone,
providing evidence that this gene could be involved in
both forms of cleft.23 The authors estimated that MSX1
mutations contributed to 2% of all NSCLP cases. A
recent study showed that the combined genetic back-
ground of rare variants of TGFA and MSX1 could increase
the risk of cleft palate by up to 9.7 times, demonstrating
the significance of gene-gene interaction in the aetiology
of NSCLP.24
5,10-Methylenetetrahydrofolate reductase
The association between folic acid deficiency and
neural tube defects has been well established. 5,10-
Methylenetetrahydrofolate reductase (MTHFR) is the
enzyme responsible for catalysing the conversion of 5,10-
methylenetetrahydrofolate into 5-methyl-tetrahydrofolate
in the folate metabolism pathway. The MTHFR C677T
single-nucleotide polymorphism (SNP) is thermally labile
and considered a risk factor of neural tube defects.25 In
NSCLP, the MTHFR C677T genotype in the mother
conferred a risk of CLP in offspring that was increased by
4.6 times.26 In peri-conceptional folic acid deficiency, the
MTHFR thermally labile variant could lead to a risk of CLP
that was increased by 10 times.27
Transforming growth factor beta-3
Mice lacking functional gene encoding transforming growth
factor beta-3 (TGFB3) displayed cleft palate because
of defective adhesion of opposing palatal shelves.28 In
humans, TGFB3 was associated with NSCLP in different
populations.24,29 A newly discovered SNP of TGFB3
(IVS5+104 A>G) increased the risk of CLP by up to 16
times in a Korean population.30
Other genes and loci
The special AT-rich sequence-binding protein-2 gene
(SATB2), located at chromosome 2q32-33, was disturbed
in two unrelated patients with cleft palate.31 Involvement of
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this gene in palatogenesis was confirmed by expression
analysis. Although an initial search for SATB2 mutations
in 70 patients with cleft palate was negative, the gene
could still be responsible for other CLP cases.
Markers from chromosome 4q21 have been linked to
familial NSCLP.32 The acyl-coenzyme A desaturase-4
gene (ACOD4) from chromosome 4q21 was recently found
disrupted in a family with cleft lip.33 Mutation analysis of
ACOD4 in families with 4q-linked CLP or other patients
with CLP might reveal more mutations.
Yoshiura et al34 reported on a family with CLP in
three generations; all affected members had a balanced
translocation at chromosome 19q13. Breakpoint cloning
revealed a novel gene termed ‘cleft lip and palate–
associated transmembrane protein-1’ (CLPTM1). Eight
rare variants of CLPTM1 were found in 74 patients with
NSCLP, but none was significantly associated with cleft
lip or palate. The authors concluded that CLPTM1 was
not a major contributor to CLP. On the other hand, the
same region of chromosome 19q13 has been implied in
NSCLP through linkage35 and transmission disequilibrium
studies.36 Thus, CLPTM1 or other genes in this locus could
still be associated with NSCLP.
Chromosome 6p23 has been indicated in NSCLP by
linkage studies.5,37 Chromosomal aberrations involving
6p23 in patients with CLP have also been reported.38 It is
therefore likely that a yet unidentified CLP gene exists at
chromosome 6p23. A summary of the above genes and
loci implied in NSCLP, with chromosomal locations and
available evidence, is shown in the Table.
Environmental factors
Smoking
The relationship between maternal smoking and CLP is
not strong, but it is significant. Several studies have
consistently yielded a relative risk of about 1.3 to 1.5.39
When maternal smoking was considered together with
certain genetic background, the combined effect was
more significant. Furthermore, van Rooij et al40 found
that maternal glutathione s-transferase θ-1 (GSTT1)
genotype, combined with smoking, could significantly
increase the risk of CLP (odds ratio=4.9). And Beaty
et al41 reported that maternal smoking and infant MSX1
genotypes contributed to an elevated risk for CLP by
7.16 times.
Alcohol use
Heavy maternal drinking, apart from causing foetal
alcohol syndrome, increases the risk of CLP. Munger et al42
showed that maternal drinking posted an increased risk
from 1.5 to 4.7 times for CLP in a dose-dependent manner.
The results were supported by Shaw and Lammer43
that mothers who consumed more than five drinks per
occasion had a 3.4 times the risk of CLP developing in the
offspring. Low-level alcohol consumption, however, did
not seem to increase the risk of orofacial clefts.44 The link
between alcohol consumption and genotypes on the risk
of CLP has yet to be shown.
Use of folic acid and multivitamins
Shaw et al45 reported that if vitamin supplements were
not taken during early pregnancy, the risk for CLP could
be tripled. Folic acid deficiency with the background of
the TGFA TaqI C2 genotype was also found to increase
the risk of CLP.46 In addition, defective maternal vitamin-
dependent homocysteine metabolism is a risk factor for
CLP in offspring: in a case-control study, mothers of
patients with CLP had a significantly higher homocysteine
level, lower level of whole-blood vitamin B6, and higher
rate of hyperhomocysteinemia.47 The role of folic acid
supplementation in the prevention of CLP has been investi-
gated in several studies. It seems that low-dose folic
acid supplementation by fortifying cereal grain products
could not protect against CLP.48 Only a very high dose of
supplementary folic acid (10 mg/d) could reduce the risk of
CLP significantly (65%).49
Table. Candidate genes or loci involved in the aetiology of non-syndromic cleft lip and palate, and available evidence
* MTHFR: 5,10-methylenetetrahydrofolate reductase; IRF6: interferon regulatory factor-6; TGFA: transforming growth factor-alpha; SATB2: special AT-rich
sequence-binding protein-2; MSX1: Drosophila msh homeo box homolog-1; ACOD4: acyl-coenzyme A desaturase-4; PVRL1: poliovirus receptor like-1;
TGFB3: transforming growth factor beta-3; CLPTM1: cleft lip and palate–associated transmembrane protein-1; TBX22: T-box transcription factor-22
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Discussion
The complexity and heterogeneity of CLP, as shown by
its extensive involvement in craniofacial syndromes and
the number of anticipated candidate genes, could be antici-
pated from the long developmental duration of the primary
and secondary palates. Disruption of the coordinated mi-
gration and fusion of various facial processes by genetic,
environmental, or combined factors at any timepoint could
lead to CLP. Genes, such as those encoding transcription
factors (eg TBX22, MSX1), growth factors (eg TGFA,
TGFB3), and adhesion molecules (eg PVRL1), have all
been implicated in the aetiology of CLP. In the search of
genes causing syndromic CLP, current methods of positional
cloning or positional candidate approaches could be applied
to families or patients. With the completion of the human
genome sequence, gene discovery is accelerated by the
availability of target sequences. Close collaboration be-
tween clinicians and scientists is still essential, as illustrated
by the example of VDWS.
The future search for genes in NSCLP will not
be straightforward. Mutations in SCLP genes or other
candidate genes so far could only be found in a handful
of NSCLP cases or families. Promising NSCLP gene
candidates, such as MSX1, was expected to cause up to
2% of NSCLP cases.23 The proportion was remarkably
similar to that of VDWS in all CLP cases. Therefore, MSX1
mutations may represent a new syndrome, which has
variable penetrance for the CLP and tooth agenesis
phenotypes.
Instead of directly searching for disease-causing
mutations in NSCLP, studies exploring the relative risk
imparted by candidate genes and gene-environmental
interactions are becoming popular approaches, for several
reasons. Firstly, the amount of sequence data, such as
SNPs, on candidate genes is constantly increasing. These
sequence data not only allow more CLP-associated muta-
tions to be identified, but functional correlation may also
be attributed to some of these subtle variations. Secondly,
high-throughput genotyping such as DNA microarray
analyses is now more readily available, so that a large number
of candidate genes and SNPs could be tested simultaneously.
In the near future, the relative contribution from these
candidate CLP genes could be integrated into a genetic
test for the weighed risk of CLP. Such data could provide
additional information on prospective parents in genetic
counselling. Preventive measures, including dietary supple-
mentation or lifestyle modification, could then be prescribed
accordingly.
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